Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: Results from the EQUIPT survey

On behalf of the EQUIPT Study Group

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: The European-study on Quantifying Utility of Investment in Protection from Tobacco (EQUIPT) project aimed to study transferability of economic evidence by co-creating the Tobacco Return On Investment (ROI) tool, previously developed in the United Kingdom, for four sample countries (Germany, Hungary, Spain and the Netherlands). The EQUIPT tool provides policymakers and stakeholders with customized information about the economic and wider returns on the investment in evidence-based tobacco control, including smoking cessation interventions. A Stakeholder Interview Survey was developed to engage with the stakeholders in early phases of the development and country adaptation of the ROI tool. The survey assessed stakeholders' information needs, awareness about underlying principles used in economic analyses, opinion about the importance, effectiveness and cost-effectiveness of tobacco control interventions, and willingness to use a Health Technology Assessment (HTA) tool such as the ROI tool. Methods: A cross sectional study using a mixed method approach was conducted among participating stakeholders in the sample countries and the United Kingdom. The individual questionnaire contained open-ended questions as well as single choice and 7- or 3-point Likert-scale questions. The results corresponding to the priority and needs assessment and to the awareness of stakeholders about underlying principles used in economic analysis are analysed by country and stakeholder categories. Results: Stakeholders considered it important that the decisions on the investments in tobacco control interventions should be supported by scientific evidence, including prevalence of smoking, cost of smoking, quality of life, mortality due to smoking, and effectiveness, cost-effectiveness and budget impact of smoking cessation interventions. The proposed ROI tool was required to provide this granularity of information. The majority of the stakeholders were aware of the general principles of economic analyses used in decision making contexts but they did not appear to have in-depth knowledge about specific technical details. Generally, stakeholders' answers showed larger variability by country than by stakeholder category. Conclusions: Stakeholders across different European countries viewed the use of HTA evidence to be an important factor in their decision-making process. Further, they considered themselves to be capable of interpreting the results from a ROI tool and were highly motivated to use it.

Original languageEnglish
Article number38
JournalHealth Research Policy and Systems
Volume14
Issue number1
DOIs
Publication statusPublished - May 26 2016

Fingerprint

Biomedical Technology Assessment
Tobacco
Economics
Smoking
Smoking Cessation
Cost-Benefit Analysis
Decision Making
Surveys and Questionnaires
Needs Assessment
Hungary
Budgets
Netherlands
Spain
Germany
Cross-Sectional Studies
Quality of Life
Interviews
Costs and Cost Analysis
Mortality

Keywords

  • EQUIPT
  • Return on investment
  • Smoking cessation
  • Stakeholder engagement
  • Transferability of economic evidence

ASJC Scopus subject areas

  • Health Policy

Cite this

@article{7cef3837116c4450a444d30a321a5a77,
title = "Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: Results from the EQUIPT survey",
abstract = "Background: The European-study on Quantifying Utility of Investment in Protection from Tobacco (EQUIPT) project aimed to study transferability of economic evidence by co-creating the Tobacco Return On Investment (ROI) tool, previously developed in the United Kingdom, for four sample countries (Germany, Hungary, Spain and the Netherlands). The EQUIPT tool provides policymakers and stakeholders with customized information about the economic and wider returns on the investment in evidence-based tobacco control, including smoking cessation interventions. A Stakeholder Interview Survey was developed to engage with the stakeholders in early phases of the development and country adaptation of the ROI tool. The survey assessed stakeholders' information needs, awareness about underlying principles used in economic analyses, opinion about the importance, effectiveness and cost-effectiveness of tobacco control interventions, and willingness to use a Health Technology Assessment (HTA) tool such as the ROI tool. Methods: A cross sectional study using a mixed method approach was conducted among participating stakeholders in the sample countries and the United Kingdom. The individual questionnaire contained open-ended questions as well as single choice and 7- or 3-point Likert-scale questions. The results corresponding to the priority and needs assessment and to the awareness of stakeholders about underlying principles used in economic analysis are analysed by country and stakeholder categories. Results: Stakeholders considered it important that the decisions on the investments in tobacco control interventions should be supported by scientific evidence, including prevalence of smoking, cost of smoking, quality of life, mortality due to smoking, and effectiveness, cost-effectiveness and budget impact of smoking cessation interventions. The proposed ROI tool was required to provide this granularity of information. The majority of the stakeholders were aware of the general principles of economic analyses used in decision making contexts but they did not appear to have in-depth knowledge about specific technical details. Generally, stakeholders' answers showed larger variability by country than by stakeholder category. Conclusions: Stakeholders across different European countries viewed the use of HTA evidence to be an important factor in their decision-making process. Further, they considered themselves to be capable of interpreting the results from a ROI tool and were highly motivated to use it.",
keywords = "EQUIPT, Return on investment, Smoking cessation, Stakeholder engagement, Transferability of economic evidence",
author = "{On behalf of the EQUIPT Study Group} and Z. Vok{\'o} and Cheung, {Kei Long} and Judit J{\'o}zwiak-Hagym{\'a}sy and Silke Wolfenstetter and Teresa Jones and Celia Mu{\~n}oz and Evers, {Silvia M A A} and Micka{\"e}l Hiligsmann and {de Vries}, Hein and Subhash Pokhrel",
year = "2016",
month = "5",
day = "26",
doi = "10.1186/s12961-016-0110-7",
language = "English",
volume = "14",
journal = "Health Research Policy and Systems",
issn = "1478-4505",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries

T2 - Results from the EQUIPT survey

AU - On behalf of the EQUIPT Study Group

AU - Vokó, Z.

AU - Cheung, Kei Long

AU - Józwiak-Hagymásy, Judit

AU - Wolfenstetter, Silke

AU - Jones, Teresa

AU - Muñoz, Celia

AU - Evers, Silvia M A A

AU - Hiligsmann, Mickaël

AU - de Vries, Hein

AU - Pokhrel, Subhash

PY - 2016/5/26

Y1 - 2016/5/26

N2 - Background: The European-study on Quantifying Utility of Investment in Protection from Tobacco (EQUIPT) project aimed to study transferability of economic evidence by co-creating the Tobacco Return On Investment (ROI) tool, previously developed in the United Kingdom, for four sample countries (Germany, Hungary, Spain and the Netherlands). The EQUIPT tool provides policymakers and stakeholders with customized information about the economic and wider returns on the investment in evidence-based tobacco control, including smoking cessation interventions. A Stakeholder Interview Survey was developed to engage with the stakeholders in early phases of the development and country adaptation of the ROI tool. The survey assessed stakeholders' information needs, awareness about underlying principles used in economic analyses, opinion about the importance, effectiveness and cost-effectiveness of tobacco control interventions, and willingness to use a Health Technology Assessment (HTA) tool such as the ROI tool. Methods: A cross sectional study using a mixed method approach was conducted among participating stakeholders in the sample countries and the United Kingdom. The individual questionnaire contained open-ended questions as well as single choice and 7- or 3-point Likert-scale questions. The results corresponding to the priority and needs assessment and to the awareness of stakeholders about underlying principles used in economic analysis are analysed by country and stakeholder categories. Results: Stakeholders considered it important that the decisions on the investments in tobacco control interventions should be supported by scientific evidence, including prevalence of smoking, cost of smoking, quality of life, mortality due to smoking, and effectiveness, cost-effectiveness and budget impact of smoking cessation interventions. The proposed ROI tool was required to provide this granularity of information. The majority of the stakeholders were aware of the general principles of economic analyses used in decision making contexts but they did not appear to have in-depth knowledge about specific technical details. Generally, stakeholders' answers showed larger variability by country than by stakeholder category. Conclusions: Stakeholders across different European countries viewed the use of HTA evidence to be an important factor in their decision-making process. Further, they considered themselves to be capable of interpreting the results from a ROI tool and were highly motivated to use it.

AB - Background: The European-study on Quantifying Utility of Investment in Protection from Tobacco (EQUIPT) project aimed to study transferability of economic evidence by co-creating the Tobacco Return On Investment (ROI) tool, previously developed in the United Kingdom, for four sample countries (Germany, Hungary, Spain and the Netherlands). The EQUIPT tool provides policymakers and stakeholders with customized information about the economic and wider returns on the investment in evidence-based tobacco control, including smoking cessation interventions. A Stakeholder Interview Survey was developed to engage with the stakeholders in early phases of the development and country adaptation of the ROI tool. The survey assessed stakeholders' information needs, awareness about underlying principles used in economic analyses, opinion about the importance, effectiveness and cost-effectiveness of tobacco control interventions, and willingness to use a Health Technology Assessment (HTA) tool such as the ROI tool. Methods: A cross sectional study using a mixed method approach was conducted among participating stakeholders in the sample countries and the United Kingdom. The individual questionnaire contained open-ended questions as well as single choice and 7- or 3-point Likert-scale questions. The results corresponding to the priority and needs assessment and to the awareness of stakeholders about underlying principles used in economic analysis are analysed by country and stakeholder categories. Results: Stakeholders considered it important that the decisions on the investments in tobacco control interventions should be supported by scientific evidence, including prevalence of smoking, cost of smoking, quality of life, mortality due to smoking, and effectiveness, cost-effectiveness and budget impact of smoking cessation interventions. The proposed ROI tool was required to provide this granularity of information. The majority of the stakeholders were aware of the general principles of economic analyses used in decision making contexts but they did not appear to have in-depth knowledge about specific technical details. Generally, stakeholders' answers showed larger variability by country than by stakeholder category. Conclusions: Stakeholders across different European countries viewed the use of HTA evidence to be an important factor in their decision-making process. Further, they considered themselves to be capable of interpreting the results from a ROI tool and were highly motivated to use it.

KW - EQUIPT

KW - Return on investment

KW - Smoking cessation

KW - Stakeholder engagement

KW - Transferability of economic evidence

UR - http://www.scopus.com/inward/record.url?scp=84970021934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84970021934&partnerID=8YFLogxK

U2 - 10.1186/s12961-016-0110-7

DO - 10.1186/s12961-016-0110-7

M3 - Article

C2 - 27230485

AN - SCOPUS:84970021934

VL - 14

JO - Health Research Policy and Systems

JF - Health Research Policy and Systems

SN - 1478-4505

IS - 1

M1 - 38

ER -